Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL Meeting Abstract


Authors: Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; Brentjens, R. J.
Abstract Title: Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901546
PROVIDER: wos
Notes: Meeting Abstract: 7010 -- Source: Wos
MSK Authors
  1. Renier J Brentjens
    187 Brentjens
  2. Kevin Joseph Curran
    56 Curran
  3. Jae Hong Park
    128 Park
  4. Craig Steven Sauter
    151 Sauter
  5. Elizabeth F Halton
    17 Halton
  6. Michel W J Sadelain
    449 Sadelain
  7. Isabelle C Riviere
    158 Riviere
  8. Xiuyan Wang
    61 Wang
  9. Yvette J Bernal
    20 Bernal
  10. Terence John Purdon
    32 Purdon
Related MSK Work